Artificial intelligence in gastrointestinal cancers: Diagnostic, prognostic, and surgical strategies
Cancer Letters · 2025-03 · 612 · 217461
DOI: 10.1016/j.canlet.2025.217461 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025-03. Verfasst von Ganji Purnachandra Nagaraju und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, 35233, USA. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Artificial Intelligence. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCI, University of Alabama at Birmingham.
Abstract (Originalsprache)
GI (Gastrointestinal) malignancies are one of the most common and lethal cancers globally. The dawn of precision medicine and developing technologies have reduced the mortality rates for GI malignancies, underscoring the main role of early detection methods for survival rate improvement. Artificial intelligence (AI) is a new technology that may improve GI cancer screening, treatment, and therapeutic efficiency for better patient care. AI could accelerate the development of targeted therapies by analyzing considerable data from the genome and identifying biomarkers connected with GI tumors. This opens up new avenues toward more tailored and personalized approaches, raising efficacy while reducing undesired side effects. For instance, AI may improve treatment outcomes by accurately predicting patient responses to therapeutic regimens, helping oncologists choose the most effective treatment options. This review will outline the transformative potential of AI in GI oncology by emphasizing the incorporation of AI-based technologies to enhance patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
- Department of Computer Science, Sri Venkateswara University, Tirupati, 517502, AP, India.
- Department of Biotechnology, Sri Venkateswara University, Tirupati, 517502, AP, India.
- Bioinformatics, Genomics and Proteomics, University of California, Irvine, Los Angeles, 92697, USA.
- School of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, 35233, USA. Electronic address: belrayes@uabmc.edu.
Förderung
- NCI NIH HHS
- NCI
- University of Alabama at Birmingham
- Comprehensive Cancer Center, University of Chicago Medical Center
Zitieren
APA
Nagaraju, G. P., Sandhya, T., Srilatha, M., Ganji, S. P., Saddala, M. S., & El-Rayes, B. F. (2025). Artificial intelligence in gastrointestinal cancers: Diagnostic, prognostic, and surgical strategies. Cancer Letters, 612, 217461. https://doi.org/10.1016/j.canlet.2025.217461
Vancouver
Nagaraju GP, Sandhya T, Srilatha M, Ganji SP, Saddala MS, El-Rayes BF. Artificial intelligence in gastrointestinal cancers: Diagnostic, prognostic, and surgical strategies. Cancer Letters. 2025;612:217461. doi:10.1016/j.canlet.2025.217461
BibTeX
@article{Nagaraju2025,
author = {Nagaraju, Ganji Purnachandra and Sandhya, Tatekalva and Srilatha, Mundla and Ganji, Swapna Priya and Saddala, Madhu Sudhana and El-Rayes, Bassel F},
title = {Artificial intelligence in gastrointestinal cancers: Diagnostic, prognostic, and surgical strategies},
journal = {Cancer Letters},
year = {2025},
volume = {612},
pages = {217461},
doi = {10.1016/j.canlet.2025.217461}
}
EUVIMED